TrialMedicine2018

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.

Youngkeun Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.